PASITHEA THERAPEUTICS CORP.: cash and cash equivalents
Cash and cash equivalents for PASITHEA THERAPEUTICS CORP. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All PASITHEA THERAPEUTICS CORP. financial histories
What this measure means
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 55,158,939 | USD | 2026-03-30 | 10-K · 0001213900-26-036434 |
| At date | 2024-12-31 | 6,922,729 | USD | 2026-03-30 | 10-K · 0001213900-26-036434 |
| At date | 2023-12-31 | 16,331,052 | USD | 2025-03-24 | 10-K · 0001013762-25-001646 |
| At date | 2022-12-31 | 33,087,864 | USD | 2024-03-29 | 10-K · 0001213900-24-027508 |
| At date | 2021-12-31 | 52,966,706 | USD | 2023-03-30 | 10-K · 0001213900-23-024755 |
| At date | 2020-12-31 | 243,650 | USD | 2022-03-30 | 10-K · 0001213900-22-016160 |
Related financial histories
- PASITHEA THERAPEUTICS CORP.: total assets
- PASITHEA THERAPEUTICS CORP.: total liabilities
- PASITHEA THERAPEUTICS CORP.: stockholders equity
- PASITHEA THERAPEUTICS CORP.: net income or loss
- PASITHEA THERAPEUTICS CORP.: operating cash flow
- PASITHEA THERAPEUTICS CORP.: capital expenditure payments
- PASITHEA THERAPEUTICS CORP.: financing cash flow
- PASITHEA THERAPEUTICS CORP.: investing cash flow
- PASITHEA THERAPEUTICS CORP.: retained earnings or deficit
- PASITHEA THERAPEUTICS CORP.: basic weighted-average shares
- PASITHEA THERAPEUTICS CORP.: diluted weighted-average shares
- PASITHEA THERAPEUTICS CORP.: basic earnings per share
- PASITHEA THERAPEUTICS CORP.: diluted earnings per share
- PASITHEA THERAPEUTICS CORP.: net property, plant and equipment
- PASITHEA THERAPEUTICS CORP.: share-based compensation expense
- PASITHEA THERAPEUTICS CORP.: operating income or loss
- PASITHEA THERAPEUTICS CORP.: current assets
- PASITHEA THERAPEUTICS CORP.: current liabilities
- PASITHEA THERAPEUTICS CORP.: net finite-lived intangible assets
- PASITHEA THERAPEUTICS CORP.: selling, general and administrative expense
- PASITHEA THERAPEUTICS CORP.: research and development expense
Inspect the source
- Entity
- PASITHEA THERAPEUTICS CORP. / CIK 0001841330
- Captured
- 2026-09-21T17:31:30.605Z
- SEC response SHA-256
2bdb4392cd4492f206adf5d15ad3afb564bdb36465949c397bd39d95f6ab7502
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001841330.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))